These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30084972)

  • 41. A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS.
    Lehmer C; Schludi MH; Ransom L; Greiling J; Junghänel M; Exner N; Riemenschneider H; van der Zee J; Van Broeckhoven C; Weydt P; Heneka MT; Edbauer D
    EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29789341
    [No Abstract]   [Full Text] [Related]  

  • 42. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.
    Zhang M; Xi Z; Fang S; Ghani M; Sato C; Moreno D; Liang Y; Lang AE; Rogaeva E
    Neurobiol Aging; 2016 Feb; 38():217.e7-217.e8. PubMed ID: 26639156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes.
    Leventoux N; Morimoto S; Ishikawa M; Nakamura S; Ozawa F; Kobayashi R; Watanabe H; Supakul S; Okamoto S; Zhou Z; Kobayashi H; Kato C; Hirokawa Y; Aiba I; Takahashi S; Shibata S; Takao M; Yoshida M; Endo F; Yamanaka K; Kokubo Y; Okano H
    Acta Neuropathol; 2024 May; 147(1):84. PubMed ID: 38750212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frontotemporal Dementia-Related V57E Mutation Impairs Mitochondrial Function and Alters the Structural Properties of CHCHD10.
    Alici H; Uversky VN; Liu T; Kang DE; Woo JA; Coskuner-Weber O
    ACS Chem Neurosci; 2023 Jun; 14(11):2134-2145. PubMed ID: 37194187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?
    Ikeda A; Imai Y; Hattori N
    Front Cell Dev Biol; 2022; 10():996061. PubMed ID: 36158221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of CHCHD10 Mutation in Chinese Patients with Alzheimer Disease.
    Xiao T; Jiao B; Zhang W; Pan C; Wei J; Liu X; Zhou Y; Zhou L; Tang B; Shen L
    Mol Neurobiol; 2017 Sep; 54(7):5243-5247. PubMed ID: 27578015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational analysis of CHCHD2 in Chinese patients with multiple system atrophy and amyotrophic lateral sclerosis.
    Yang X; An R; Zhao Q; Zheng J; Tian S; Chen Y; Xu Y
    J Neurol Sci; 2016 Sep; 368():389-91. PubMed ID: 27538669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
    Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
    Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
    Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
    Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CHCHD10 is not a frequent causative gene in Chinese ALS patients.
    Li XL; Shu S; Li XG; Liu Q; Liu F; Cui B; Liu MS; Peng B; Cui LY; Zhang X
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):458-60. PubMed ID: 27077676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China.
    Shen S; He J; Tang L; Zhang N; Fan D
    Neurobiol Aging; 2017 Jun; 54():214.e7-214.e10. PubMed ID: 28318595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
    Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
    Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CHCHD2 mutational screening in Brazilian patients with familial Parkinson's disease.
    Voigt DD; Nascimento CM; de Souza RB; Cabello Acero PH; Campos Júnior M; da Silva CP; Pereira JS; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Della Coletta MV; da Silva DJ; Nicaretta DH; Gonçalves AP; Dos Santos JM; Calassara V; Santos-Rebouças CB; Pimentel MMG
    Neurobiol Aging; 2019 Feb; 74():236.e7-236.e8. PubMed ID: 30342766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?
    Dobson-Stone C; Shaw AD; Hallupp M; Bartley L; McCann H; Brooks WS; Loy CT; Schofield PR; Mather KA; Kochan NA; Sachdev PS; Halliday GM; Piguet O; Hodges JR; Kwok JB
    Brain; 2015 Oct; 138(Pt 10):e385. PubMed ID: 25953780
    [No Abstract]   [Full Text] [Related]  

  • 56. Screening for CHCHD10 mutations in a large cohort of sporadic ALS patients: no evidence for pathogenicity of the p.P34S variant.
    Marroquin N; Stranz S; Müller K; Wieland T; Ruf WP; Brockmann SJ; Danzer KM; Borck G; Hübers A; Weydt P; Meitinger T; Strom TM; Rosenbohm A; Ludolph AC; Weishaupt JH
    Brain; 2016 Feb; 139(Pt 2):e8. PubMed ID: 26362909
    [No Abstract]   [Full Text] [Related]  

  • 57. CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability.
    Genin EC; Bannwarth S; Ropert B; Lespinasse F; Mauri-Crouzet A; Augé G; Fragaki K; Cochaud C; Donnarumma E; Lacas-Gervais S; Wai T; Paquis-Flucklinger V
    Brain; 2022 Oct; 145(10):3415-3430. PubMed ID: 35656794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population.
    Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Guo QH; Wang G
    J Alzheimers Dis; 2018; 61(4):1283-1288. PubMed ID: 29376860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.
    Ronchi D; Riboldi G; Del Bo R; Ticozzi N; Scarlato M; Galimberti D; Corti S; Silani V; Bresolin N; Comi GP
    Brain; 2015 Aug; 138(Pt 8):e372. PubMed ID: 25576308
    [No Abstract]   [Full Text] [Related]  

  • 60. Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?
    van Rheenen W; Diekstra FP; van den Berg LH; Veldink JH
    Brain; 2014 Dec; 137(Pt 12):e313. PubMed ID: 25348631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.